Souhaitez-vous accéder aux communiqués récents ?

RALEIGH, Carolina del Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) ha anunciado hoy el nombramiento de Glen Stettin, doctor en medicina, como consejero del...

RALEIGH, Carolina do Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ:PRAH) anunciou hoje a nomeação do Doutor Glen Stettin para o Conselho de Administração da Empresa,...

RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) hari mengumumkan pelantikan Glen Stettin, M.D. kepada Lembaga Pengarah Syarikat, berkuat kuasa pada 14...

RALEIGH, Caroline du Nord, 16 sept. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination de Glen Stettin, M.D., au conseil d'administration de la...

北卡罗来纳州罗利, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ:PRAH）今天宣布任命Glen Stettin为公司董事，任命自2020年9月14日起生效。 ...

RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective...

Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million...

RALEIGH, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its second quarter 2020 results after the market closes on Thursday, August 6, 2020. The...

RALEIGH, N.C., June 19, 2020 (GLOBE NEWSWIRE) -- Antara tahun 2007-2017, 78 agen kanser dewasa yang baharu telah diluluskan oleh Pentadbiran Makanan dan Ubat-ubatan A.S.,1 tetapi tiada satu pun ubat...

北卡罗来纳州罗利市, June 19, 2020 (GLOBE NEWSWIRE) -- 2007-2017年间，美国食品药品管理局批准了78种新型成人癌症药物，1 但其中没有任何一种药物完成了旨在确定其针对儿科癌症功效的研究。 ...